Parallax Volatility Advisers, L.P. Apellis Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

A detailed history of Parallax Volatility Advisers, L.P. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 149,000 shares of APLS stock, worth $4.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

149,000

Holding current value

$4.94 Million

% of portfolio

0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $1.46 Million - $2.55 Million	39,392 New	39,392 $2.36 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $1.48 Million - $2.13 Million	-31,791 Reduced 99.72%	89 $5,000
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $1.96 Million - $2.76 Million	-45,273 Reduced 58.68%	31,880 $1.65 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $1.3 Million - $2.03 Million	29,090 Added 60.52%	77,153 $5.27 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $1.69 Million - $2.85 Million	48,053 Added 480530.0%	48,063 $2.17 Million
Q1 2022 May 16, 2022	SELL	$35.46 - $54.12 $387,435 - $591,315	-10,926 Reduced 99.91%	10 $1,000
Q4 2021 Feb 14, 2022	BUY	$30.74 - $49.16 $334,820 - $535,450	10,892 Added 24754.55%	10,936 $517,000
Q3 2021 Nov 15, 2021	SELL	$31.4 - $69.84 $1.46 Million - $3.24 Million	-46,370 Reduced 99.91%	44 $1,000
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $1.9 Million - $3.01 Million	46,414 New	46,414 $2.93 Million
Q3 2020 Nov 13, 2020	SELL	$25.89 - $33.65 $10,174 - $13,224	-393 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $347,274 - $538,975	-14,003 Reduced 97.27%	393 $13,000
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $217,642 - $538,698	12,152 Added 541.53%	14,396 $386,000
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $49,592 - $69,115	2,244 New	2,244 $69,000
Q1 2018 May 15, 2018	SELL	$14.01 - $26.02 $23,536 - $43,713	-1,680 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.71 - $21.7 $21,352 - $36,456	1,680	1,680 $36,000

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account

Parallax Volatility Advisers, L.P. Apellis Pharmaceuticals, Inc. Transaction History